MDS/Myeloproliferative Neoplasm (MPN) Overlap Syndrome

Explore clinical trials studying MDS/Myeloproliferative Neoplasm (MPN) Overlap Syndrome. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

MDS/Myeloproliferative Neoplasm (MPN) Overlap Syndrome trial results

Not Yet Recruiting

Dresden MDS Registry With an Accompanying Biomaterial Collection

NCT07561385

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +8 more
Locations: Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany

View Trial Details

Completed

A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

NCT05665530

Conditions: Acute Myeloid Leukemia (AML), Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Bone Marrow Diseases, +41 more
Locations: City of Hope Duarte, California, United States

American Oncology Partners of Maryland, PA Bethesda, Maryland, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States

View all 24 locations

View Trial Details

MDS/Myeloproliferative Neoplasm (MPN) Overlap Syndrome

MDS/Myeloproliferative Neoplasm (MPN) Overlap Syndrome trial results

Dresden MDS Registry With an Accompanying Biomaterial Collection

A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

Related conditions